Omkar Speciality Chemicals has filed one more application for the grant of Patent for preparing 4-Bromo-Ortho-Phenylene-Diamine, a key precursor for making of the drug namely Ledipasvir. Ledipasvir is a drug for the treatment of Hepatitis C.
Omkar Speciality Chemicals (including its wholly owned subsidiaries) has 9 Units in the State of Maharashtra, India (5 Units in Badlapur, Dist: Thane, 3 Units in Chiplun, Dist: Ratnagiri and 1 Unit in Mahad, Dist: Raigad) with a total volumetric installed capacity of 4920 MTPA.
